HSBC Holdings’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
HSBC Holdings's CTMX Position: Q3 2026 in Review
HSBC Holdings sold out of CytomX Therapeutics (CTMX) in Q3 2026, closing a stake of 26,636 shares — an estimated $103K sold.
HSBC Holdings first reported a position in CTMX in Q2 2018 and held it in 9 quarters. The position peaked at $222K in Q2 2018. 194 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- HSBC Holdings reported no remaining CytomX Therapeutics position as of Q3 2026 after selling out during the quarter.
- HSBC Holdings sold 26,636 CytomX Therapeutics shares in Q3 2026, an estimated $103K.
- HSBC Holdings first reported a position in CytomX Therapeutics in Q2 2018 and held it in 9 quarters.
- HSBC Holdings's CytomX Therapeutics position peaked at $222K in Q2 2018.
- 194 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.